Last reviewed · How we verify
coronary artery disease and left ventricular dysfunction
Approved treatments
- Fludeoxyglucose F-18 · Downstate Clincl
Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions. - Fludeoxyglucose F-18 · 3D Imaging Drug
Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- coronary artery disease and left ventricular dysfunction patent landscape — cliff calendar, originator estates, attackable patents
- coronary artery disease and left ventricular dysfunction treatment landscape brief
- coronary artery disease and left ventricular dysfunction treatment updates RSS
Frequently asked questions about coronary artery disease and left ventricular dysfunction
What drugs treat coronary artery disease and left ventricular dysfunction?
Tracked treatments include Fludeoxyglucose F-18.
What is the treatment for coronary artery disease and left ventricular dysfunction?
Standard treatment for coronary artery disease and left ventricular dysfunction includes Fludeoxyglucose F-18. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: coronary artery disease and left ventricular dysfunction patent cliff · coronary artery disease and left ventricular dysfunction CI report
- Treatment: Fludeoxyglucose F-18 · Downstate Clincl
- Treatment: Fludeoxyglucose F-18 · 3D Imaging Drug
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing